Gyon Technologies Capital Management, LP Kura Oncology, Inc. Transaction History

Gyon Technologies Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$11.23 - $16.9 $107,235 - $161,378	9,549 New	9,549 $118,000
Q4 2021 Feb 11, 2022	SELL	$12.22 - $19.57 $1.07 Million - $1.72 Million	-87,805 Closed	0 $0
Q3 2021 Nov 18, 2021	BUY	$15.42 - $21.72 $1.35 Million - $1.91 Million	87,805 New	87,805 $1.65 Million
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $310,547 - $583,753	-19,052 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $151,463 - $358,368	19,052 New	19,052 $311,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.